查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750817

北美和歐洲藥物穩定性服務市場規模、佔有率和趨勢分析報告：按服務、分子、國家和細分市場預測，2025 年至 2030 年

North America And Europe Pharmaceutical Stability & Storage Services Market Size, Share & Trends Analysis Report By Services (Stability, Storage), By Molecule (Large Molecule, Small Molecule), By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

北美和歐洲藥品穩定儲存服務市場的成長和趨勢：

預計到 2030 年北美和歐洲醫藥倉儲服務市場規模將達到 19.2 億美元。

根據 Grand View Research, Inc. 的最新報告，預計預測期內的複合年成長率為 6.4%。嚴格的監管要求、不斷增加的研發投資以及臨床試驗的全球化是推動市場成長的一些關鍵因素。

生物相似藥需求的不斷成長預計將推動市場發展。近年來，生物相似藥的核准率顯著提高。根據安進公司2020年發布的《生物相似藥趨勢報告》，美國核准的生物相似藥數量較前一年增加了65%。截至2023年，美國已批准41種生物相似藥，歐盟已核准超過70種生物相似藥。生物相似藥核准的擴大可能會對市場產生正面影響。

此外，這些地區日益轉向個人化醫療，因此需要根據個人化治療特徵量身訂做穩定性測試，以確保針對特定患者的治療方案有效。自動化、進階數據分析、即時監控技術整合、穩定性測試流程的簡化以及更快的決策速度等技術進步也正在改變產業格局。這些進步提高了業務效率，並提供了對產品行為的即時洞察，進一步推動了市場成長。

此外，北美和歐洲的製藥業受益於高度發展的基礎設施，其擁有先進的穩定性測試和儲存設施，能夠滿足現代藥品（包括溫度敏感型產品）的複雜需求。此外，新藥研發線的不斷成長，尤其是那些具有特殊儲存需求和較短保存期限的藥物，例如生技藥品和特種藥物，也推動了對先進穩定性儲存解決方案的需求。

北美和歐洲藥品穩定性服務市場報告重點：

  • 穩定性測試部分在服務部分佔據主導地位，2024 年的收入佔有率最大，為 73.8%。生物製藥和個人化醫療需求的快速成長正在推動藥物穩定性服務的進步。
  • 由於發展中地區對學名藥和生物相似藥的關注度不斷提高，預計預測期內儲存領域的複合年成長率將達到 5.8%。
  • 小分子藥物領域將佔據市場主導地位，到 2024 年將佔據 79.4% 的最大收入佔有率。預測、基於結構的設計、成像、自動化、人工智慧和機器學習的最新進展是提高小分子先導藥物最適化速度和成功率的關鍵驅動力。
  • 由於蛋白質、核酸、碳水化合物、生物細胞和組織等大分子的應用日益廣泛，預計聚合物領域將在 2025 年至 2030 年間以顯著的複合年成長率成長。
  • 北美在藥品穩定性服務市場佔據主導地位，因為包括生技藥品和個人化藥物在內的複雜藥品數量不斷增加，需要專門的穩定性測試和受控儲存解決方案，從而刺激了市場擴張。
  • 預計未來幾年歐洲也將佔據相當大的市場佔有率。英國正專注於藥物研發。隨著企業投資開發新藥並進行臨床試驗，對支援這些活動的穩定性測試和儲存服務的需求日益成長。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 北美和歐洲藥物穩定性服務市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 北美及歐洲醫藥穩定儲存服務市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第4章北美和歐洲藥品穩定性服務市場分析（按服務）

  • 服務細分儀表板
  • 醫藥穩定倉儲服務市場：服務波動分析
  • 北美及歐洲醫藥穩定儲存服務市場規模及趨勢分析（按服務，2018-2030 年）
  • 穩定性測試
  • 貯存

5. 北美和歐洲藥物穩定性服務市場-分子分析

  • 分子細分儀表板
  • 藥品穩定儲存服務市場：依分子波動分析
  • 北美及歐洲醫藥穩定儲存服務市場規模及趨勢分析（按分子，2018-2030 年）
  • 小分子
  • 大分子

6. 北美和歐洲醫藥穩定儲存服務市場：國家分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美及歐洲藥品倉儲服務市場（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key Company Heat Map Analysis, 2024
  • 公司簡介
    • Eurofins Scientific
    • Intertek Group plc
    • Lucideon Limited
    • Element Materials Technology
    • Q1 Scientific
    • Reading Scientific Services Ltd.
    • Catalent, Inc.
    • Quotient Sciences
    • Recipharm AB
    • Almac Group
    • Alcami Corporation
    • BioLife Solutions, Inc.
    • Sampled（Roylance Stability Storage Limited）
    • Precision Stability Storage
    • Broughton
Product Code: GVR-4-68040-123-7

North America And Europe Pharmaceutical Stability & Storage Services Market Growth & Trends:

The North America and Europe pharmaceutical stability & storage services market is anticipated to reach USD 1.92 billion by 2030. It is anticipated to expand at a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. Stringent regulatory requirements, increasing R&D investments, and globalization of clinical trials are some of the major factors driving market growth.

The rising demand for biosimilars is expected to drive market advancement. In recent years, the approval rate for biosimilars has significantly improved. As per the Amgen Biosimilars Trend Report published in 2020, the number of biosimilar approvals in the U.S. increased by 65% since the preceding year. As of 2023, 41 biosimilars were approved in the U.S., and over 70 were approved in the EU. The growing approval of biosimilars is likely to impact the market positively.

In addition, the shift toward personalized medicine in these regions necessitates stability testing tailored to the distinct features of individualized treatments, ensuring that patient-specific therapies remain effective. Technological innovations have also transformed the landscape, integrating automation, advanced data analytics, and real-time monitoring technologies, streamlining stability testing processes, and accelerating decision-making. These advancements enhance operational effectiveness and provide immediate insights into product behavior, further propelling market growth.

Furthermore, the pharmaceutical industries in North America and Europe benefit from highly developed infrastructure equipped with state-of-the-art facilities for stability testing and storage, supporting the complex requirements of modern pharmaceuticals, including temperature-sensitive products. The increasing pipeline of new drugs, especially biologics and specialty medicines with unique storage needs and shorter shelf lives, also drives demand for advanced stability and storage solutions.

North America And Europe Pharmaceutical Stability & Storage Services Market Report Highlights:

  • The stability testing segment dominated the service segment. It held the largest revenue share of 73.8% in 2024. The rapid growth in the demand for biopharmaceuticals and personalized medicines is driving advancements in pharmaceutical stability services
  • The storage segment is expected to grow at a CAGR of 5.8% over the forecast period, owing to the increasing focus on generics and biosimilars in developing regions.
  • The small molecules segment dominated the market, with the largest revenue share of 79.4% in 2024. Recent advances in forecasting, structure-based design, imaging, automation, artificial intelligence, and machine learning have become critical facilitators for increasing small molecules lead optimization's pace and success rates
  • The large molecules segment is expected to grow at a significant CAGR from 2025 to 2030. This is due to the increasing adoption of large molecules such as proteins, nucleic acids, carbohydrates, living cells, and tissues.
  • North America dominated the pharmaceutical stability & storage services market. It held the largest revenue share in 2024, driven by the growing pipeline of complex drugs, including biologics and personalized medicines, necessitating specialized stability testing and controlled storage solutions, fueling market expansion.
  • Europe is also expected to account for a significant market share in the coming years. The UK has a strong emphasis on R&D in the pharmaceutical sector. As companies invest in developing new drugs and conducting clinical trials, there is an increased demand for stability testing and storage services to support these activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Molecule
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service Outlook
    • 2.2.2. Molecule Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. North America and Europe Pharmaceutical Stability and Storage Services Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. North America and Europe Pharmaceutical Stability and Storage Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. North America and Europe Pharmaceutical Stability and Storage Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • 4.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
  • 4.4. Stability Testing
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Drug Substance
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Stability Indicating Method Validation
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Accelerated Stability Testing
      • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Photo Stability Testing
      • 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Other Stability Testing Methods
      • 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Storage
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Cold
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Non-Cold
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Business Analysis

  • 5.1. Molecule Segment Dashboard
  • 5.2. Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • 5.3. North America and Europe Pharmaceutical Stability and Storage Services Market Size & Trend Analysis, By Molecule, 2018 to 2030 (USD Million)
  • 5.4. Small Molecule
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Research Products
      • 5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Commercial Products
      • 5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Large Molecule
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Research Products
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Commercial Products
      • 5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. North America and Europe Pharmaceutical Stability and Storage Services Market: Country Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America and Europe Pharmaceutical Stability and Storage Services Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key Country Dynamics
      • 6.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.1.3. Competitive Scenario
      • 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Germany
      • 6.5.1.1. Key Country Dynamics
      • 6.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.1.3. Competitive Scenario
      • 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 6.5.8.3. Competitive Scenario
      • 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key Company Heat Map Analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Eurofins Scientific
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Intertek Group plc
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Lucideon Limited
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Element Materials Technology
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Q1 Scientific
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Reading Scientific Services Ltd.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Catalent, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Quotient Sciences
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Recipharm AB
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Almac Group
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Alcami Corporation
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. BioLife Solutions, Inc.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Sampled (Roylance Stability Storage Limited)
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Precision Stability Storage
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives
    • 7.4.15. Broughton
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 North America and Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 3 North America and Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 4 North America and Europe Pharmaceutical Stability and Storage Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 8 U.S. Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 10 Canada Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 12 Mexico Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 14 Europe Pharmaceutical Stability and Storage Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 17 Germany Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 18 Germany Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 21 France Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 22 France Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 23 Italy Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 24 Italy Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 25 Spain Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 26 Spain Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 27 Denmark Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 28 Denmark Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 29 Sweden Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 30 Sweden Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)
  • Table 31 Norway Pharmaceutical Stability and Storage Services Market, By Service, 2018 - 2030 (USD Million)
  • Table 32 Norway Pharmaceutical Stability and Storage Services Market, By Molecule, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 North America and Europe Pharmaceutical Stability and Storage Services Market: Market Outlook
  • Fig. 10 North America and Europe Pharmaceutical Stability and Storage Services Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 North America and Europe Pharmaceutical Stability and Storage Services Market Driver Impact
  • Fig. 16 North America and Europe Pharmaceutical Stability and Storage Services Market Restraint Impact
  • Fig. 17 North America and Europe Pharmaceutical Stability and Storage Services Market Strategic Initiatives Analysis
  • Fig. 18 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Movement Analysis
  • Fig. 19 North America and Europe Pharmaceutical Stability and Storage Services Market: Service Outlook and Key Takeaways
  • Fig. 20 Stability Testing Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Storage Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Movement Analysis
  • Fig. 23 North America and Europe Pharmaceutical Stability and Storage Services Market: Molecule Outlook and Key Takeaways
  • Fig. 24 Small Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 25 Large Molecule Market Estimates and Forecasts, 2018 - 2030
  • Fig. 26 North America and Europe Pharmaceutical Stability and Storage Services Market: Regional Outlook and Key Takeaways
  • Fig. 27 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 28 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 29 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 30 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 31 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 32 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Norway Market Estimates and Forecasts, 2018 - 2030